Analystreport

Array Biopharma Inc (NASDAQ: ARRY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Array Technologies, Inc.  (ARRY) 
Last array technologies, inc. earnings: 5/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arraybiopharma.com/investor-overview